La Fleur & Godfrey LLC Merck & Co., Inc. Transaction History

La Fleur & Godfrey LLC

$723 Million
Q3 2024

A detailed history of La Fleur & Godfrey LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, La Fleur & Godfrey LLC holds 103,083 shares of MRK stock, worth $10.3 Million. This represents 1.62% of its overall portfolio holdings.

Number of Shares

103,083

Previous 105,413 2.21%

Holding current value

$10.3 Million

Previous $13.1 Million 10.3%

% of portfolio

1.62%

Previous 1.92%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$111.15 - $128.97 $258,979 - $300,500	-2,330 Reduced 2.21%	103,083 $11.7 Million
Q2 2024 Jul 23, 2024	SELL	$123.8 - $132.96 $146,826 - $157,690	-1,186 Reduced 1.11%	105,413 $13.1 Million
Q1 2024 Apr 23, 2024	SELL	$113.24 - $131.95 $755,084 - $879,842	-6,668 Reduced 5.89%	106,599 $14.1 Million
Q4 2023 Jan 18, 2024	SELL	$100.18 - $109.02 $56,301 - $61,269	-562 Reduced 0.49%	113,267 $12.3 Million
Q3 2023 Oct 18, 2023	SELL	$102.95 - $114.33 $64,343 - $71,456	-625 Reduced 0.55%	113,829 $11.7 Million
Q2 2023 Jul 20, 2023	SELL	$108.61 - $118.38 $71,682 - $78,130	-660 Reduced 0.57%	114,454 $13.2 Million
Q1 2023 Apr 18, 2023	SELL	$102.94 - $114.86 $607,963 - $678,363	-5,906 Reduced 4.88%	115,114 $12.2 Million
Q4 2022 Jan 12, 2023	SELL	$87.44 - $112.11 $1.76 Million - $2.26 Million	-20,150 Reduced 14.27%	121,020 $0
Q3 2022 Oct 17, 2022	SELL	$84.53 - $94.96 $957,133 - $1.08 Million	-11,323 Reduced 7.43%	141,170 $12.2 Million
Q2 2022 Jul 26, 2022	SELL	$83.49 - $94.64 $552,703 - $626,516	-6,620 Reduced 4.16%	152,493 $13.9 Million
Q1 2022 May 03, 2022	BUY	$73.51 - $82.4 $164,515 - $184,411	2,238 Added 1.43%	159,113 $13.1 Million
Q4 2021 Jan 26, 2022	BUY	$72.28 - $90.54 $372,097 - $466,099	5,148 Added 3.39%	156,875 $12 Million
Q3 2021 Nov 01, 2021	SELL	$71.68 - $78.83 $114,472 - $125,891	-1,597 Reduced 1.04%	151,727 $11.4 Million
Q2 2021 Jul 19, 2021	BUY	$70.31 - $77.77 $2.19 Million - $2.43 Million	31,189 Added 25.54%	153,324 $11.9 Million
Q1 2021 Apr 30, 2021	SELL	$68.86 - $81.11 $2.11 Million - $2.48 Million	-30,590 Reduced 20.03%	122,135 $9.42 Million
Q4 2020 Jan 26, 2021	SELL	$71.77 - $79.65 $153,874 - $170,769	-2,144 Reduced 1.38%	152,725 $12.5 Million
Q3 2020 Nov 04, 2020	SELL	$73.18 - $82.95 $403,807 - $457,718	-5,518 Reduced 3.44%	154,869 $12.8 Million
Q2 2020 Jul 28, 2020	SELL	$70.42 - $80.13 $73,800 - $83,976	-1,048 Reduced 0.65%	160,387 $12.4 Million
Q1 2020 May 04, 2020	SELL	$63.36 - $87.82 $266,682 - $369,634	-4,209 Reduced 2.54%	161,435 $12.4 Million
Q4 2019 Feb 04, 2020	SELL	$77.58 - $87.54 $153,220 - $172,891	-1,975 Reduced 1.18%	165,644 $15.1 Million
Q3 2019 Oct 29, 2019	SELL	$76.08 - $82.93 $193,851 - $211,305	-2,548 Reduced 1.5%	167,619 $14.1 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $21,580 - $25,211	-309 Reduced 0.18%	170,167 $14.3 Million
Q1 2019 Apr 17, 2019	SELL	$69.58 - $79.36 $514,126 - $586,391	-7,389 Reduced 4.15%	170,476 $14.2 Million
Q4 2018 Feb 12, 2019	SELL	$65.24 - $75.71 $2.15 Million - $2.49 Million	-32,949 Reduced 15.63%	177,865 $13.6 Million
Q3 2018 Dec 13, 2018	SELL	$57.69 - $67.84 $176,704 - $207,793	-3,063 Reduced 1.43%	210,814 $15 Million
Q2 2018 Dec 13, 2018	SELL	$50.83 - $59.72 $224,058 - $263,245	-4,408 Reduced 2.02%	213,877 $13 Million
Q1 2018 Dec 13, 2018	SELL	$50.96 - $59.23 $615,342 - $715,202	-12,075 Reduced 5.24%	218,285 $11.9 Million
Q4 2017 Jan 22, 2018	SELL	$51.62 - $61.64 $595,694 - $711,325	-11,540 Reduced 4.77%	230,360 $13 Million
Q3 2017 Oct 26, 2017	BUY	$58.67 - $63.13 $14.2 Million - $15.3 Million	241,900	241,900 $15.5 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of La Fleur & Godfrey LLC, based on Form 13F filings with the SEC.

News

Stay updated on La Fleur & Godfrey LLC with notifications on news.

Account

La Fleur & Godfrey LLC Merck & Co., Inc. Transaction History